Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
- NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
- NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_assertion evidence source_evidence_literature NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
- NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_assertion SIO_000772 23770046 NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
- NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_assertion wasDerivedFrom befree-20140225 NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
- NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_assertion wasGeneratedBy ECO_0000203 NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.